84499-77-4 Usage
General Description
1-(4-Bromophenyl)ethylamine hydrochloride, also known as 4-Bromo-α-ethylphenethylamine hydrochloride or 4-B-PEA, is a chemical compound that falls under the category of alkaloids. It is a derivative of phenethylamine and is commonly used in research and scientific studies. This chemical is known to exhibit psychoactive properties, potentially affecting behavior and cognitive functions. It is often studied for its potential use in pharmacology and medicinal chemistry, particularly in the development of new drugs that target the central nervous system. Additionally, it has been the subject of interest for its potential role in the treatment of various neurological and psychiatric disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 84499-77-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,4,9 and 9 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 84499-77:
(7*8)+(6*4)+(5*4)+(4*9)+(3*9)+(2*7)+(1*7)=184
184 % 10 = 4
So 84499-77-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H10BrN.ClH/c1-6(10)7-2-4-8(9)5-3-7;/h2-6H,10H2,1H3;1H
84499-77-4Relevant articles and documents
N-BENZYLBENZIMIDAZOLE MODULATORS OF PPARG
-
Page/Page column 64-65, (2013/06/06)
The invention provides molecular entities that bind with high affinity to PPARG (PPAR?), inhibit cdk5-mediated phosphorylation of PPARG, but do not exert an agonistic effect on PPARG. Compounds of the invention can be used for treatment of conditions in patients wherein PPARG plays a role, such as diabetes or obesity. Methods of preparation of the compounds, bioassay methods for evaluating compounds of the invention as non-agonistic PPARG binding compounds, and pharmaceutical compositions are also provided.
[1, 2, 4] TRIAZOLO [1, 5-A] PYRIDINES AS JAK INHIBITORS
-
Page/Page column 108; 109, (2010/04/03)
Novel [1,2,4]triazolo[1,5-a]pyridine compounds are disclosed that have a Formula represented by the following: (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, joint disease, inflammation, and others.